Oral Contraceptive Pills Global Market Sees Growth Rate Of 12% Through 2026

The global contraceptive pills market size is expected to grow from $18.44 billion in 2021 to $20.13 billion in 2022 at a compound annual growth rate (CAGR) of 9.2%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global oral contraceptive pills market is expected to reach $31.92 billion in 2026 at a CAGR of 12.2%.

What is the Global Oral Contraceptive Pills Market?

The oral contraceptive pills market consists of sales of oral contraceptive pills by entities (organizations, sole traders, and partnerships) that are engaged in manufacturing oral contraceptive pills. An oral contraceptive pill is a pill used to discourage pregnancy. It comprises hormones that prevent the emergence of eggs from the ovaries. Most oral contraceptives involve estrogen and progestin.

Get a Sample of the global oral contraceptive pills market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3900&&type=smp

What drives the Global Oral Contraceptive Pills Market?

The high incidence of unintended pregnancies is expected to drive the growth of the oral contraceptive pills market over the coming years. Unintended pregnancy is a pregnancy that is always unwanted, such as a pregnancy where no children have been planned. The University of California, San Francisco (UCSF) study shows that the rates of unwanted pregnancy and abortion declined substantially when women received a one-year prescription of oral contraceptives. According to the World Health Organization (WHO), 74 million women living in low middle-income economies register unplanned pregnancies every year globally. The WHO’s research noticed 4,794 women had an unplanned pregnancy after they had discontinued using contraceptives. Therefore, the need to avoid unintended pregnancies drives the growth of the oral contraceptive pills market.

Get the full global oral contraceptive pills industry report here:

Global Oral Contraceptive Pills Market Segments
The global oral contraceptive pills market is segmented:
By Type: Combination, Progestin Only, Others
By Category: Generic, Branded
By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinic, Online Channel, Public Channel and NGO, Other
By Geography: The regions covered in the oral contraceptive pills market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Oral Contraceptive Pills Global Market Report 2022provides market size and growth forecasts for the global oral contraceptive pills market, global oral contraceptive pills market share, oral contraceptive pills market segments and geographies, oral contraceptive pills market competitive landscape including leading competitors’ revenues, profiles and market shares. The oral contraceptive pills market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Global Oral Contraceptive Pills Industry Playersinclude Teva Pharmaceutical Industries Ltd, Bayer AG, Syzygy Healthcare, Mankind Pharma Ltd., Pfizer Inc., Piramal Enterprises Ltd., Ferring B.V, Merck & Co. Inc., Johnson & Johnson and Lupin Pharmaceuticals Inc. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.